Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease
Maya Koronyo‐Hamaoui, Julia Sheyn, Eric Y. Hayden, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 336-358
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Alzheimer’s disease and its treatment by different approaches: A review
Sukriti Srivastava, Razi Ahmad, Sunil Kumar Khare
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113320-113320
Closed Access | Times Cited: 334
Retinal pathological features and proteome signatures of Alzheimer’s disease
Yosef Koronyo, Altan Rentsendorj, Nazanin Mirzaei, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 409-438
Open Access | Times Cited: 82
Alzheimer's disease pathophysiology in the Retina
Bhakta Prasad Gaire, Yosef Koronyo, Dieu‐Trang Fuchs, et al.
Progress in Retinal and Eye Research (2024) Vol. 101, pp. 101273-101273
Open Access | Times Cited: 21
Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives
Yuan Cheng, Ding‐Yuan Tian, Yan‐Jiang Wang
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 123
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
Thanigaimalai Pillaiyar, Sangeetha Meenakshisundaram, Manoj Manickam, et al.
European Journal of Medicinal Chemistry (2020) Vol. 195, pp. 112275-112275
Open Access | Times Cited: 113
Alzheimer’s Retinopathy: Seeing Disease in the Eyes
Nazanin Mirzaei, Haoshen Shi, Mia Oviatt, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 92
Angiotensin converting enzyme (ACE)
Vatsala Khurana, Binita Goswami
Clinica Chimica Acta (2021) Vol. 524, pp. 113-122
Closed Access | Times Cited: 78
Identification of novel drug targets for Alzheimer’s disease by integrating genetics and proteomes from brain and blood
Ya‐Nan Ou, Yuxiang Yang, Yue‐Ting Deng, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 6065-6073
Closed Access | Times Cited: 69
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Xin Zang, Si Chen, Junyao Zhu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 62
Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus
Clara Muñoz‐Castro, Marina Mejias‐Ortega, Elisabeth Sánchez‐Mejías, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
Duo‐Yao Cao, Zakir Khan, Xiaomo Li, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 9, pp. 1825-1841
Open Access | Times Cited: 29
A genome‐wide association meta‐analysis of all‐cause and vascular dementia
Bernard Fongang
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 5973-5995
Open Access | Times Cited: 9
Peroxisome proliferator-activated receptor alpha is an essential factor in enhanced macrophage immune function induced by angiotensin-converting enzyme
Suguru Saito, Duo‐Yao Cao, Ellen A. Bernstein, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 1
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Sihan Chen, Ding‐Yuan Tian, Ying‐Ying Shen, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 66
CD36 in Alzheimer’s Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting
Ana-Maria Dobri, Maria Dudău, Ana‐Maria Enciu, et al.
Neuroscience (2020) Vol. 453, pp. 301-311
Open Access | Times Cited: 63
Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model
Tamar Smit, Natasja A. C. Deshayes, David Borchelt, et al.
Glia (2021) Vol. 69, Iss. 8, pp. 1852-1881
Open Access | Times Cited: 54
Exploring the Impact of ACE Inhibition in Immunity and Disease
Delia Oosthuizen, Edward D. Sturrock
Journal of the Renin-Angiotensin-Aldosterone System (2022) Vol. 2022
Open Access | Times Cited: 28
Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models
Jonah Doustar, Altan Rentsendorj, Tania Torbati, et al.
Aging Cell (2020) Vol. 19, Iss. 11
Open Access | Times Cited: 39
Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls
Giulia Cisbani, Serge Rivest
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5504-5515
Closed Access | Times Cited: 38
Chronic peripheral inflammation: a possible contributor to neurodegenerative diseases
JohannesC. M. Schlachetzki, Patrick Süβ, Addison J. Lana
Neural Regeneration Research (2021) Vol. 16, Iss. 9, pp. 1711-1711
Open Access | Times Cited: 36
Trans-synaptic degeneration in the visual pathway: Neural connectivity, pathophysiology, and clinical implications in neurodegenerative disorders
Samridhi Sharma, Nitin Chitranshi, Roshana Vander Wall, et al.
Survey of Ophthalmology (2021) Vol. 67, Iss. 2, pp. 411-426
Closed Access | Times Cited: 34
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice
Antonietta Vilella, Martina Bodria, Bianca Papotti, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 517-534
Open Access | Times Cited: 15
Computational Studies Applied to Linalool and Citronellal Derivatives Against Alzheimer's and Parkinson's Disorders: A Review with Experimental Approach
Pablo Rayff da Silva, Jéssica Andrade, Natália Ferreira de Sousa, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 842-866
Open Access | Times Cited: 13
Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging
Duc Le, Lindsay Brown, Kundan Malik, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13178-13178
Open Access | Times Cited: 31
VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration
Fangfang Qi, Zejie Zuo, Kaishun Hu, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4374-4389
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top